Designed as a way to bring potentially life-changing drugs to pharmacy shelves faster than ever, the Food and Drug Administration Safety and Innovation Act, which passed last year, came with a clause allowing the FDA to place a special designation, known as "breakthrough therapy," on clinical-stage drugs.
http://www.fool.com/investing/general/2013/08/31/these-2-companies-are-the-biggest-winners-of-the-f.aspx
http://www.fool.com/investing/general/2013/08/31/these-2-companies-are-the-biggest-winners-of-the-f.aspx
No comments:
Post a Comment